Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Enterprise Value (2010 - 2026)

Lite Strategy (LITS) posted Enterprise Value of $33.2 million for Q1 2026, down 15.3% on a QoQ basis from $39.2 million in Q4 2025, and up 662.57% year-over-year from $4.4 million in Q1 2025.

Analysis

Lite Strategy (LITS) Enterprise Value (2010 - 2026) Analysis & Trends

Lite Strategy has reported Enterprise Value for 17 years, with the latest figure at $33.2 million in Q1 2026.

  • On a quarterly basis, Enterprise Value rose 662.57% year-over-year to $33.2 million in Q1 2026; TTM through Mar 2026 was $33.2 million, a 662.57% increase from a year earlier, with the FY2025 full-year figure at -$1.6 million, up 91.81% from the prior year.
  • Enterprise Value was $33.2 million for Q1 2026 at Lite Strategy, down from $39.2 million in the prior quarter.
  • The five-year high for Enterprise Value was $61.2 million in Q3 2025, with the low at -$247.1 million in Q1 2022.
  • Average Enterprise Value over 5 years is -$69.3 million, with a median of -$56.9 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 4918.52% in 2022, then jumped 662.57% in 2026.
  • Over 5 years, Enterprise Value stood at -$205.5 million in 2022, then soared by 63.42% to -$75.2 million in 2023, then jumped by 90.22% to -$7.3 million in 2024, then soared by 634.02% to $39.2 million in 2025, then retreated by 15.3% to $33.2 million in 2026.
  • The last three Enterprise Value figures came in at $33.2 million (Q1 2026), $39.2 million (Q4 2025), and $61.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 33.24 Mn
Dec 31, 2025 39.24 Mn
Sep 30, 2025 61.22 Mn
Jun 30, 2025 -1.55 Mn
Mar 31, 2025 -5.91 Mn
Dec 31, 2024 -7.35 Mn
Sep 30, 2024 -27.91 Mn
Jun 30, 2024 -18.96 Mn
Mar 31, 2024 -84.15 Mn
Dec 31, 2023 -75.16 Mn
Sep 30, 2023 -114.32 Mn
Jun 30, 2023 -56.86 Mn
Mar 31, 2023 -184.61 Mn
Dec 31, 2022 -205.49 Mn
Sep 30, 2022 -210.11 Mn
Jun 30, 2022 -72.03 Mn
Mar 31, 2022 -247.08 Mn
Dec 31, 2021 -4.09 Mn
Sep 30, 2021 35.61 Mn
Jun 30, 2021 22.63 Mn